Ascend Theraps Us patents expiration

1. Binosto patents expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents protects the active chemical substance. Only drug patent owner can launch products that use this active substance.
US7964212 ASCEND THERAPS US Effervescent compositions comprising phosphonates and methods related thereto
Mar, 2023

(6 months ago)

US7488496 ASCEND THERAPS US Effervescent compositions comprising bisphosphonates and methods related thereto
Aug, 2023

(a month ago)

These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US9592195 ASCEND THERAPS US Stable effervescent bisphosphonate formulations with rapid solubilization characteristics
Dec, 2031

(8 years from now)

Drugs and Companies using ALENDRONATE SODIUM ingredient

Market Authorisation Date: 12 March, 2012

Treatment: NA


More Information on Dosage

BINOSTO family patents

Family Patents

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic